| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
63,029,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases. Co. has developed a proprietary product engine, FulcrumSeek, that it employs to systematically identify and validate cellular drug targets. Co.' products include: losmapimod, a small molecule that it is developing for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive and disabling disorder characterized by muscle degeneration and fat infiltration; and FTX-6058, an investigational oral fetal hemoglobin, inducer that is in development for sickle cell disease and select other hemoglobinopathies, including ss-thalassemia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
43,360 |
43,360 |
43,360 |
4,472,361 |
| Total Buy Value |
$492,028 |
$492,028 |
$492,028 |
$39,173,214 |
| Total People Bought |
1 |
1 |
1 |
2 |
| Total Buy Transactions |
1 |
1 |
1 |
7 |
| Total Shares Sold |
4,884 |
4,884 |
5,094 |
149,917 |
| Total Sell Value |
$57,219 |
$57,219 |
$57,914 |
$1,270,109 |
| Total People Sold |
1 |
1 |
1 |
2 |
| Total Sell Transactions |
1 |
1 |
2 |
7 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tourangeau Greg |
Vice President, Finance |
• – – |
2024-03-08 |
4 |
S |
$11.72 |
$57,219 |
D/D |
(4,884) |
11,807 |
|
- |
|
| Sapir Alex |
See Remarks |
• • – |
2024-03-04 |
4 |
B |
$11.35 |
$492,028 |
D/D |
43,360 |
43,360 |
0.01 |
- |
|
| Tourangeau Greg |
Principal Accounting Officer |
• – – |
2023-05-10 |
4 |
S |
$3.31 |
$695 |
D/D |
(210) |
15,992 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2023-01-20 |
4 |
B |
$13.00 |
$24,999,988 |
I/I |
1,923,076 |
11,609,704 |
1.5 |
- |
|
| Gould Robert J |
Interim President & CEO |
• • – |
2023-01-13 |
4 |
AS |
$15.00 |
$101,490 |
D/D |
(6,766) |
499,864 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2022-12-27 |
4 |
B |
$5.99 |
$24,510 |
I/I |
4,089 |
9,505,925 |
1.5 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2022-12-19 |
4 |
B |
$5.90 |
$582,814 |
I/I |
98,787 |
9,501,836 |
1.5 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2022-12-16 |
4 |
B |
$5.42 |
$7,269,826 |
I/I |
1,341,420 |
9,403,049 |
1.5 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2022-12-15 |
4 |
B |
$5.50 |
$1,302,474 |
I/I |
237,029 |
8,061,629 |
1.5 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2022-12-14 |
4 |
B |
$5.46 |
$4,501,574 |
I/I |
824,600 |
7,824,600 |
1.5 |
- |
|
| Tepper Robert I |
10% Owner |
– – • |
2022-12-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,000,000) |
1,962,202 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2022-08-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,000,000 |
|
- |
|
| Gould Robert J |
Director |
– • – |
2022-06-07 |
4 |
AS |
$8.09 |
$577,895 |
D/D |
(71,435) |
506,630 |
|
- |
|
| Gould Robert J |
Director |
– • – |
2022-06-07 |
4 |
OE |
$7.84 |
$560,050 |
D/D |
71,435 |
578,065 |
|
- |
|
| Gould Robert J |
Director |
– • – |
2022-06-06 |
4 |
AS |
$8.10 |
$197,592 |
D/D |
(24,382) |
506,630 |
|
- |
|
| Gould Robert J |
Director |
– • – |
2022-06-06 |
4 |
OE |
$7.84 |
$191,155 |
D/D |
24,382 |
531,012 |
|
- |
|
| Gould Robert J |
Director |
– • – |
2022-06-03 |
4 |
AS |
$7.95 |
$203,056 |
D/D |
(25,551) |
506,630 |
|
- |
|
| Gould Robert J |
Director |
– • – |
2022-06-03 |
4 |
OE |
$7.84 |
$200,320 |
D/D |
25,551 |
532,181 |
|
- |
|
| Gould Robert J |
Director |
– • – |
2022-06-02 |
4 |
AS |
$7.92 |
$132,162 |
D/D |
(16,689) |
506,630 |
|
- |
|
| Gould Robert J |
Director |
– • – |
2022-06-02 |
4 |
OE |
$7.84 |
$130,842 |
D/D |
16,689 |
523,319 |
|
- |
|
| Tourangeau Greg |
Controller |
• – – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,250 |
16,202 |
|
- |
|
| Gould Robert J |
Director |
– • – |
2022-04-07 |
4 |
AS |
$24.02 |
$135,228 |
D/D |
(5,631) |
506,630 |
|
- |
|
| Gould Robert J |
Director |
– • – |
2022-04-07 |
4 |
OE |
$7.84 |
$44,147 |
D/D |
5,631 |
512,261 |
|
- |
|
| Gould Robert J |
Director |
– • – |
2022-04-05 |
4 |
AS |
$24.26 |
$1,274,775 |
D/D |
(52,552) |
506,630 |
|
- |
|
| Gould Robert J |
Director |
– • – |
2022-04-05 |
4 |
OE |
$7.84 |
$412,008 |
D/D |
52,552 |
559,182 |
|
- |
|
122 Records found
|
|
Page 1 of 5 |
|
|
